Skip to main content
. 2019 Nov 29;9:17963. doi: 10.1038/s41598-019-54292-x

Figure 2.

Figure 2

Cell lineage immunophenotyping in small airways. (A) IHC for MUC5AC (goblet cells), in small airways of a control and a COPD patient. (B) Quantification of MUC5AC staining in small airways expressed in percentage of positive area (n = 54). (C) IHC for ß-tubulin IV (ciliated cells) in small airways of a control and a COPD patient. (D) Quantification of ß-tubulin IV staining in small airways expressed in percentage of positive area (n = 54). (E) IHC for p63 (basal cells) in small airways of a control and a COPD patient. (F) Quantification of p63 staining in small airways expressed in percentage of positive cells (n = 54). (G) IHC for CK13 (basal cells) in small airways of a control and a COPD patient. (H) Quantification of CK13 staining in small airways expressed in percentage of positive cells (n = 41). Scale bar, 50 µm. White dots represent non-smoker controls and black dots current smoker controls, grey squares represent mild and moderate COPD and black squares severe and very severe COPD. Mann-Whitney U test.